MarketBeat on MSN
Stoke Therapeutics Q1 earnings call highlights
Stoke Therapeutics (NASDAQ:STOK) said its lead investigational therapy zorevunersen continued to show durable seizure ...
It further cemented its position at the top of the world of high-frequency trading ahead of Wall Street’s top investment ...
Jane Street pulled in a record haul of $16.1 billion in trading revenue for the first three months of the year, as the Wall ...
A DWP spokesperson said: "Since 2021, nearly two thirds of award reviews have resulted in no change – that's why we've ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results